Flexzo AI, a healthcare workforce orchestration startup, has raised $12 million in a Series A funding round led by Octopus Ventures, with participation from Fuel Ventures. The financing will support continued adoption across NHS Trusts and accelerate expansion in the United States.
It was created to address chronic workforce shortages and escalating agency spend in healthcare. Founder and CEO Jack Henderson previously ran a clinical insourcing company delivering services to NHS patients, where he observed how outdated processes, poor visibility, and fragmented compliance workflows made staffing more difficult and expensive. Hospitals subscribe to the platform to access workforce tools, technology, and a national talent pool, removing the need for agency mark-ups, with no placement fees charged.
At NHS partner sites, it has reduced agency spend by up to 85%, while over 65% of all shifts advertised outside a hospital’s internal workforce are filled through the platform. This is achieved through a combination of workforce management systems and a growing supply of healthcare professionals. The platform includes rostering tools, internal workforce management systems, collaborative technology connecting teams across sites, and a national database of pre-verified clinicians. Its system also expands the candidate pool by sourcing and onboarding clinicians when external agencies are used, strengthening workforce supply over time.
The platform uses a matching engine to identify workforce gaps, validate compliance in real time, and route demand to the lowest-cost safe staffing option. It is designed for hospital environments to ensure appropriate staffing levels while improving visibility, compliance oversight, and operational efficiency.
The investment will accelerate rollout to additional NHS Trusts and international partners, and support expansion of implementation capacity. It has already secured its first US-based healthcare clients and will continue investing in its team to expand product capabilities and develop its models for more complex clinical environments. As part of the investment, Uthish Ranjan and Shiv Patel will join the board, and Professor Rupert Shute has been appointed Non-Executive Chairman. Flexzo AI was previously incorporated as Healsgood AI LTD.
We are excited to support Flexzo in applying AI where it truly matters. The strong ROI impact already delivered across NHS Trusts - alongside early traction in the US - demonstrates both the urgency of the problem and the strength of the product.
While LLMs dominate the headlines, it’s companies like Flexzo applying AI to real-world operational challenges that are driving meaningful impact today. The team is quietly delivering tangible ROI for healthcare systems, and that’s where we see the biggest long-term value.
The way healthcare organisations manage their workforce hasn’t fundamentally changed in decades. Until now. Hospitals shouldn’t be forced to rely on inefficient processes and spiralling agency costs. With Flexzo AI, we’re delivering the step change in efficiency the system urgently needs.
